nonstructur
protein
hepat
c
viru
hcv
serv
dual
function
viral
rna
replic
viru
assembl
demonstr
hcv
replic
complex
along
core
protein
transport
lipid
droplet
ld
microtubul
complex
transport
ld
earlytol
endosom
plasma
membran
via
microtubul
studi
cofraction
analysi
immunoelectron
microscopi
releas
particl
show
complex
present
lowdens
fraction
highdens
fraction
hcv
rnacontain
virion
associ
intern
virion
core
furthermor
exosom
marker
also
detect
lowdens
fraction
highdens
fraction
overal
result
suggest
hcv
associ
core
lowdens
viru
particl
exit
cell
preexist
endosomeexosom
pathway
may
contribut
hcv
natur
infect
hepat
c
viru
hcv
major
caus
agent
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
hcv
envelop
viru
positivestrand
rna
genom
genom
encod
larg
polyprotein
process
host
viral
proteas
viral
protein
consist
three
structur
protein
six
nonstructur
protein
small
hydrophob
peptid
structur
protein
core
protein
two
envelop
glycoprotein
deriv
n
termin
portion
polyprotein
constitut
physic
virion
compon
nonstructur
ns
protein
deriv
c
termin
portion
polyprotein
ns
protein
except
involv
hcv
replic
hcv
rna
synthes
replic
complex
rc
exist
membran
web
deriv
alter
er
membran
hcv
rc
transport
microtubul
transport
facilit
interact
tubulin
intact
microtubul
network
also
directli
involv
hcv
rna
replic
viru
releas
follow
hcv
rna
replic
core
protein
serv
central
regul
viru
assembl
core
protein
form
multim
interact
viral
rna
form
viral
nucleocapsid
core
protein
local
mainli
surfac
lipid
droplet
ld
essenti
product
infecti
hcv
particl
core
protein
promot
accumul
ld
facilit
viru
assembl
recruit
viral
rc
ldassoci
membran
therebi
viral
rna
interact
core
protein
juxtaposit
ld
viru
packag
moreov
interact
core
protein
essenti
recruit
viral
rc
ld
play
import
role
viru
assembl
howev
viral
rc
core
protein
target
ld
remain
unclear
addit
ns
protein
includ
also
shown
influenc
product
infecti
viru
known
whether
ns
protein
incorpor
infecti
virion
previou
studi
indic
cell
cultur
patient
serumderiv
hcv
particl
display
heterogen
diamet
nm
broad
rang
buoyant
densiti
gml
gml
main
peak
viral
core
protein
rna
exhibit
densiti
gml
cell
cultur
derivedhcv
hcvcc
highest
specif
infect
extracellular
virion
observ
densiti
gml
notabl
lowdens
fraction
densiti
gml
display
exosomelik
structur
also
contain
infect
natur
origin
properti
still
unknown
mani
type
cell
continu
secret
larg
number
microvesicl
call
exosom
diamet
approxim
nm
buoyant
densiti
gml
gml
exosom
releas
extracellular
space
late
endosomesmultivesicular
bodi
mvb
fusion
plasma
membran
recent
exosom
deriv
cell
contain
hcv
subgenom
replicon
demonstr
contain
hcv
rna
viral
ns
protein
previou
result
shown
hcv
core
protein
transport
earli
late
endosomesmvb
hcvinfect
cell
howev
known
whether
hcv
protein
incorpor
releas
exosom
hcvinfect
cell
studi
traffick
mechan
core
protein
defin
core
protein
found
close
associ
cotransport
along
microtubul
perinuclear
region
cell
via
ld
endosom
plasma
membran
associ
protein
implic
viru
assembl
well
releas
interestingli
found
core
addit
exosom
protein
detect
lowdens
hcv
particl
gml
lowgrad
infect
appear
incorpor
hcv
particl
interact
core
protein
microtubul
intracellular
transport
data
suggest
lowdens
hcv
particl
releas
form
exosom
cell
mutant
line
cell
support
hcv
replic
high
effici
cultur
dulbecco
modifi
eagl
medium
dmem
contain
either
fetal
bovin
serum
fb
dialyz
fb
gener
subcultur
prepar
purifi
hcv
respect
rep
cell
cell
harbor
genotyp
hcv
subgenom
replicon
grown
aforement
medium
contain
mgml
plasmid
encod
chimera
genom
hcv
construct
previous
describ
antibodi
use
studi
includ
austral
biolog
anticor
affin
bioreag
inc
antibromodeoxyuridin
sigmaaldrich
santa
cruz
biotechnolog
mous
bd
pharmingen
rabbit
santa
cruz
biotechnolog
genetex
inc
anticalnexin
assay
designsstressgen
antimous
orrabbit
colloid
gold
conjug
jackson
immunoresearch
inc
rabbit
polyclon
ab
core
describ
previous
primari
ab
btubulin
nonspecif
normal
mous
immunoglobulin
g
igg
obtain
sigmaaldrich
secondari
ab
mous
rabbit
goat
purchas
invitrogen
molecular
probe
reagent
use
nocodazol
sigmaaldrich
taxol
paclitaxel
sigmaaldrich
bodipi
invitrogen
molecular
probe
dapi
invitrogen
molecular
probe
wheatgerm
agglutinin
wga
alexa
fluor
conjug
invitrogen
molecular
probe
virus
produc
titrat
cell
base
previous
describ
method
batch
cultur
supernat
virusinfect
control
cell
includ
hcv
subgenom
replicon
cell
hcv
assemblydefect
replicon
cell
uninfect
cell
use
experi
concentr
hcv
control
subject
sucros
gradient
sediment
centrifug
previous
describ
total
fraction
ml
collect
bottom
top
sucros
gradient
monitor
hcv
rna
use
quantit
pcr
qpcr
fraction
contain
hcv
rna
signal
fraction
fraction
uninfect
counterpart
pool
dialyz
tne
buffer
mm
tri
mm
nacl
mm
ethylen
diamin
tetraacet
acid
overnight
viruscontain
fraction
concentr
concentr
devic
millipor
process
electron
microscopi
applic
infect
infect
fraction
determin
quantifi
amount
intracellular
hcv
rna
level
day
postinfect
pi
cell
sixwel
plate
infect
concentr
hcv
fraction
sucros
gradient
suspend
dmem
h
cell
wash
pb
incub
ml
dmem
contain
fb
day
postinfect
total
rna
isol
cell
lysat
use
high
pure
rna
isol
kit
roch
viral
rna
isol
cell
cultur
supernat
use
qiaamp
viral
rna
kit
qiagen
qrtpcr
perform
describ
previous
procedur
em
carri
exactli
describ
previous
immunoem
sampl
first
incub
anticor
mous
mab
follow
incub
colloid
gold
particl
nm
conjug
antimous
immunoglobulin
g
immunoem
purifi
virus
two
microlit
purifi
viru
adsorb
onto
carbonco
grid
grid
fix
paraformaldehyd
min
block
solut
bovin
serum
albumin
bsa
min
grid
incub
primari
ab
normal
mous
igg
overnight
grid
wash
incub
goat
antimous
andor
goat
antirabbit
colloid
gold
particl
diamet
h
room
temperatur
extens
wash
grid
stain
uranyl
acet
min
analysi
hcv
core
particl
purifi
viru
treat
saponin
pb
min
process
sampl
analyz
tecnai
spirit
transmiss
electron
microscop
fei
co
kv
cell
label
brutp
perform
accord
method
describ
previous
hcvinfect
cell
day
pi
grown
chamber
slide
one
day
seed
cell
incub
actinomycin
mgml
min
ml
brutp
fugen
roch
molecular
biochem
mixtur
ad
well
contain
ml
medium
actinomycin
mg
ml
min
incub
cell
treat
mm
nocodazol
taxol
h
fix
process
immunofluoresc
stain
describ
cell
gown
glass
chamber
slide
cell
fixat
immunostain
perform
method
describ
listenberg
l
l
brown
photograph
cell
taken
confoc
microscop
zeiss
confoc
laser
scan
microscop
lsm
procedur
quantit
coloc
analysi
use
studi
follow
publish
method
weight
coloc
coeffici
sum
intens
coloc
pixel
rel
overal
sum
pixel
intens
threshold
use
determin
rel
level
figur
coloc
core
protein
microtubul
lipid
droplet
hcvinfect
cell
day
pi
costain
antitubulin
green
red
andor
core
red
b
blue
c
antibodi
lipid
droplet
ld
stain
bodypi
blue
b
brown
c
nuclei
dapi
gray
stain
cell
examin
confoc
fluoresc
microscop
merg
imag
green
red
blue
gray
channel
gener
pictur
fig
b
fig
c
gener
merg
imag
green
red
blue
brown
channel
yellow
indic
overlap
local
green
red
channel
cyan
indic
overlap
local
green
blue
channel
magenta
indic
overlap
local
red
blue
channel
white
indic
overlap
local
red
green
blue
channel
upper
third
panel
fig
shown
core
red
red
dapi
blue
lower
panel
fig
c
respect
coloc
effici
ld
core
protein
b
ld
analyz
use
zeiss
lsm
zen
softwar
e
analysi
cellular
prolifer
surviv
mt
assay
f
g
quantit
confoc
microscop
fluoresc
signal
core
cell
total
fluoresc
intens
core
protein
measur
use
metamorph
integr
morphometri
analysi
total
cell
use
calcul
coloc
effici
total
fluoresc
intens
two
independ
experi
error
bar
repres
standard
deviat
mean
noc
nocodazol
bar
mm
h
parallel
cell
lysat
collect
immunoblot
antibodi
core
result
quantifi
phosphorimag
count
transfect
brutp
presenc
actinomycin
h
treat
either
mm
nocodazol
mm
taxol
h
cell
costain
mous
mab
bromodeoxyuridin
green
rabbit
polyclon
antibodi
core
red
ld
nuclei
stain
bodypi
blue
dapi
cyan
respect
enlarg
view
part
everi
imag
shown
inset
b
number
brutplabel
viral
rna
count
manual
use
origin
magnif
follow
quantit
analysi
perform
observ
blind
experiment
treatment
c
averag
distanc
center
signal
emit
brutplabel
viral
rna
coloc
core
protein
protein
interest
eg
calnexin
ld
shortest
longest
averag
distanc
brutplabel
viral
rna
signal
center
nearest
edg
ld
calcul
manual
use
zen
softwar
zen
light
edit
carl
zeiss
inc
number
brutplabel
viral
rna
antibodylabel
signal
viral
protein
plasma
membran
manual
count
origin
magnif
total
fluoresc
intens
valu
core
protein
individu
cell
measur
use
metamorph
softwar
univers
imag
corpor
use
bit
imag
grayscal
imag
rang
black
white
imag
analysi
carri
use
integr
morphometri
analysi
program
provid
metamorph
fluoresc
intens
express
integr
valu
pixel
per
cell
exceed
inclus
threshold
valu
set
total
cell
use
experiment
condit
two
independ
experi
queou
one
solut
cell
prolifer
assay
kit
promega
use
evalu
cell
viabil
perform
describ
previous
previou
studi
shown
microtubul
provid
track
movement
hcv
rc
interact
transport
requir
viru
releas
propos
microtubul
also
provid
track
transport
rc
core
protein
reach
ld
viru
assembl
occur
test
possibl
first
investig
whether
corecontain
ld
coloc
associ
microtubul
hcvinfect
cell
day
postinfect
pi
immunofluoresc
stain
reveal
core
protein
togeth
fig
either
one
alon
fig
coloc
surfac
ld
close
associ
tubulin
microtubul
network
requir
traffick
replic
complex
core
protein
lipid
droplet
use
nocodazol
induc
microtubul
depolymer
taxol
stabil
tubulin
polymer
examin
whether
intact
microtubul
requir
transport
core
protein
viral
rc
ld
cell
first
infect
hcv
treat
either
nocodazol
taxol
hr
pi
day
coloc
coeffici
ld
core
protein
calcul
condit
cell
viabil
affect
reveal
salt
mt
assay
fig
control
condit
dimethyl
sulfoxid
dmso
ld
coloc
core
protein
throughout
entir
cytoplasm
includ
perinuclear
region
proport
ld
coloc
core
protein
cell
treat
increas
concentr
nocodazol
dosedepend
decreas
coloc
coeffici
ld
core
protein
observ
fig
upper
panel
coloc
coeffici
ld
also
decreas
correspondingli
fig
upper
panel
taxol
effect
coeffici
order
rule
possibl
dosedepend
decreas
coloc
ld
core
nocodazol
treatment
might
consequ
decreas
amount
core
protein
analysi
core
protein
fig
lower
panel
fig
lower
panel
label
cell
carri
use
metamorph
integr
morphometri
analysi
nocodazoletr
cell
signific
chang
total
fluoresc
intens
core
rel
control
cell
fig
immunoblot
analysi
also
show
level
core
protein
cell
significantli
affect
low
concentr
mm
nocodazol
taxol
use
fig
contrast
effect
nocodazol
mm
use
publish
studi
inhibit
hcv
rna
replic
therebi
hcv
protein
level
data
support
conclus
nocodazol
treatment
low
concentr
affect
coloc
core
ld
fig
fig
taken
togeth
result
indic
microtubul
involv
transport
core
protein
ld
newli
synthes
membran
protein
gener
leav
endoplasm
reticulum
er
transport
destin
cell
therefor
next
investig
whether
core
protein
transport
er
ld
along
microtubul
presenc
dmso
taxol
core
protein
coloc
er
marker
protein
calnexin
throughout
entir
cytoplasm
includ
perinuclear
region
coloc
coeffici
fig
contrast
nocodazol
treatment
caus
dosedepend
increas
coloc
coeffici
mm
nocodazol
respect
fig
upper
panel
similarli
coloc
coeffici
calnexin
increas
respect
fig
upper
panel
thu
nocodazol
treatment
caus
increas
accumul
core
protein
er
correspond
decreas
ld
taken
togeth
result
suggest
core
protein
transloc
er
ld
microtubuledepend
manner
confirm
mode
transport
hcv
rc
ld
immunofluoresc
label
newli
synthes
hcv
rna
brutp
dmso
control
taxoltr
cell
number
brutplabel
speckl
averag
per
cell
averag
distanc
speckl
ld
mm
fig
presenc
nocodazol
number
speckl
reduc
averag
per
cell
fig
indic
hcv
rna
replic
partial
suppress
nocodazol
treatment
consist
previou
report
correspondingli
averag
distanc
speckl
center
nearest
edg
ld
increas
mm
dmso
control
taxoltr
cell
mm
nocodazoletr
cell
fig
suggest
hcv
rc
normal
deliv
vicin
ld
microtubul
transport
disrupt
nocodazol
taken
togeth
data
suggest
nearest
edg
ld
hcv
rnald
distanc
analyz
use
zeiss
lsm
zen
softwar
total
cell
use
quantit
calcul
hcv
rnald
distanc
number
brutplabel
viral
rna
two
independ
experi
error
bar
repres
standard
deviat
mean
ns
nonsignific
noc
nocodazol
bar
mm
core
protein
complex
cotransport
perinuclear
region
plasma
membran
via
microtubul
togeth
core
protein
involv
viru
assembl
assembl
virion
presum
transport
plasma
membran
releas
cell
therefor
next
analyz
whether
involv
postassembl
process
viral
life
cycl
purpos
examin
coloc
core
protein
two
region
cytoplasm
viz
perinuclear
region
around
nucleu
peripher
region
underneath
plasma
membran
region
hcvinfect
cell
costain
fluoresc
alexa
wga
bind
glycoprotein
cell
membran
serv
membran
marker
anticor
either
ab
shown
fig
core
protein
coloc
perinuclear
region
cell
peripheri
contrast
coloc
core
protein
perinuclear
region
cytoplasm
peripher
region
analysi
larg
number
cell
indic
core
protein
coloc
throughout
entir
cytoplasm
fig
upper
panel
total
fraction
coloc
core
protein
correspond
fig
lower
panel
complex
coloc
peripher
region
cell
wherea
coloc
region
fig
next
examin
possibl
complex
also
transport
along
microtubul
cell
peripheri
dmsotreat
cell
coloc
core
protein
perinuclear
peripher
region
treatment
either
nocodazol
vinblastin
complex
cluster
almost
exclus
perinuclear
region
fig
result
suggest
microtubul
requir
transport
complex
cell
peripheri
observ
suggest
involv
postassembl
transport
viru
particl
evalu
involv
complex
hcv
assembl
releas
investig
local
complex
respect
ld
earli
late
endosom
microtubul
involv
variou
step
hcv
assembl
exit
hcvinfect
cell
costain
ld
marker
bodipi
earli
endosom
marker
earli
endosom
antigen
late
endosom
marker
lysosomeassoci
membran
microtubul
marker
btubulin
perinuclear
region
cytoplasm
complex
coloc
ld
earli
endosom
fig
contrast
peripher
region
complex
coloc
late
endosom
fig
immunoelectron
microscopi
immunoem
show
late
endosomemvb
contain
latter
mainli
perinuclear
region
fig
result
suggest
strongli
complex
transport
earlytol
endosom
follow
viru
assembl
ld
furthermor
core
protein
coloc
microtubul
peripher
region
cytoplasm
especi
microtubul
end
closest
cell
peripheri
fig
final
character
relationship
complex
plasma
membran
hcvinfect
cell
costain
fluoresc
alexa
wga
anticor
ab
shown
fig
core
protein
coloc
plasma
membran
particularli
membran
curvatur
report
essenti
viru
exit
quantit
analysi
show
number
anticor
antibodieslabel
signal
plasma
membran
averag
per
cell
respect
wherea
less
interestingli
signal
contain
core
per
cell
averag
also
detect
plasma
membran
wherea
signal
found
fig
furthermor
immunoem
show
fig
core
protein
complex
fig
local
mainli
patch
cluster
plasma
membran
taken
togeth
result
suggest
least
complex
assembl
virion
transport
ld
earlytol
endosom
plasma
membran
via
microtubul
confirm
releas
plasma
membran
compon
virion
particl
cultur
hcvinfect
cell
dialyz
serum
reduc
nonspecif
bind
irrelev
protein
viru
particl
cultur
supernat
subject
sucros
gradient
sediment
distribut
viral
rna
infect
hcv
figur
complex
transport
perinuclear
region
earli
late
endosom
hcvinfect
cell
day
pi
label
antibodi
specif
core
protein
red
green
upper
row
green
lower
row
plasma
membran
nuclei
stain
wga
alexa
fluor
conjug
blue
dapi
gray
respect
parallel
panel
hcvinfect
cell
label
antibodi
core
protein
green
red
red
b
upper
row
nuclei
stain
dapi
blue
coloc
effici
core
protein
analyz
use
zeiss
lsm
zen
softwar
b
lower
panel
error
bar
repres
standard
deviat
mean
cell
two
independ
experi
imag
analyz
use
metamorph
proport
cell
count
coloc
core
protein
cell
peripheri
calcul
c
effect
nocodazol
noc
vinblastin
vbl
movement
protein
complex
cell
peripheri
hcvinfect
cell
day
pi
treat
nocodazol
vinblastin
dmso
h
cell
label
antibodi
core
protein
green
red
nuclei
stain
dapi
blue
imag
differenti
interfer
contrast
dic
fluoresc
imag
merg
enlarg
view
part
imag
shown
inset
parallel
panel
hcvinfect
cell
label
antibodi
core
protein
red
e
f
g
green
e
f
g
upper
row
green
e
f
g
lower
row
blue
f
blue
g
ld
nuclei
stain
bodypi
blue
e
dapi
gray
respect
second
third
panel
row
magnifi
view
mark
white
box
panel
extrem
left
perinuclear
peripher
region
cytoplasm
respect
e
f
g
coloc
core
protein
depict
yellow
b
e
f
g
coloc
complex
ld
e
earli
endosom
f
late
endosom
g
depict
white
bar
mm
h
parallel
hcvinfect
cell
label
ab
bound
antibodi
detect
use
antimous
rabbit
secondari
antibodi
conjug
gold
particl
respect
section
visual
em
arrow
goldlabel
nm
nm
indic
mvb
contain
sever
intravesicular
vesicl
white
arrow
enlarg
view
perinuclear
region
lower
left
imag
shown
inset
arrow
goldlabel
pm
plasma
membran
mvb
multivesicular
bodi
n
nucleu
nm
nuclear
membran
bar
nm
left
panel
nm
right
panel
determin
two
peak
one
fraction
densiti
gml
sucros
lowdens
fraction
ldf
anoth
fraction
densiti
gml
sucros
highdens
fraction
hdf
found
contain
distinct
hcv
rna
signal
fig
fraction
gml
sucros
contain
largest
amount
viral
rna
consist
previous
report
densiti
free
hcv
virion
fraction
analyz
infect
naiv
cell
result
show
ldf
hdf
cultur
supernat
contain
infect
fig
hdf
approxim
higher
specif
infect
thu
ldf
hdf
infecti
ldf
contain
total
infect
thu
possibl
appar
infect
ldf
may
come
contamin
hdf
rule
analyz
variou
fraction
possibl
presenc
core
shown
fig
hdf
contain
abund
core
protein
contrast
lowdens
fraction
gml
contain
addit
core
protein
recent
studi
reveal
hcv
virion
releas
requir
late
endosom
multivesicular
bodi
mvb
function
endosom
sort
complex
requir
transport
escrt
hepatocyt
receptor
tyrosin
kinas
substrat
hr
involv
biogenesi
mvb
exosom
secret
addit
hcv
particl
associ
circul
exosom
hepat
patient
serum
therefor
investig
whether
hcv
virion
releas
cell
membran
occur
exosom
pathway
probe
sucros
densiti
fraction
presenc
two
exosom
marker
viz
interestingli
detect
ldf
fig
hdf
suggest
exosom
involv
ldf
viru
releas
sinc
exosom
deriv
endosom
also
secret
normal
cell
particip
varieti
cellular
function
also
analyz
sucros
gradient
fraction
extracellular
medium
obtain
cell
cell
harbor
hcv
subgenom
replicon
none
fraction
obtain
cell
contain
hcv
protein
data
shown
consist
previou
report
data
suggest
ldf
contain
hcv
particl
releas
exosomelik
structur
contain
morpholog
composit
viru
particl
ldf
hdf
character
diamet
particl
rang
nm
n
nm
n
lowand
highdens
pool
respect
fig
size
heterogen
hcv
particl
describ
previous
correspondingli
particl
nm
nm
diamet
probabl
repres
lowand
highdens
viru
particl
respect
observ
extracellular
space
surround
hcvinfect
cell
fig
treatment
saponin
remov
viral
envelop
size
particl
reduc
nm
ldf
hdf
virus
fig
consist
intern
viral
core
next
purifi
virion
character
presenc
viral
protein
exosom
marker
immunoem
particl
lowdens
pool
could
stain
mab
purifi
normal
igg
mab
fig
upper
panel
ab
data
shown
contrast
protein
detect
highdens
pool
fig
lower
panel
associ
hcv
envelop
protein
exosom
previous
report
follow
treatment
viru
sampl
deterg
saponin
virion
core
lowand
highdens
pool
stain
anticor
mab
fig
interestingli
virion
core
ldf
hdf
could
stain
antibodi
neither
normal
igg
antibodi
fig
parallel
saponintr
viru
ldf
could
stain
core
simultan
fig
specif
stain
confirm
stain
variou
treatment
condit
fig
viru
sampl
normal
igg
antibodi
yield
background
stain
hdf
antibodi
also
yield
littl
stain
without
saponin
treatment
contrast
ldf
stain
intact
viru
sampl
strongli
anticor
stain
saponintr
sampl
strongli
result
prompt
us
character
local
exosom
protein
rel
core
protein
plasma
membran
result
indic
core
protein
coloc
plasma
membran
immunofluoresc
stain
fig
immunoem
fig
result
suggest
hcv
particl
exit
cell
via
fusion
mvb
plasma
membran
taken
togeth
data
suggest
minor
popul
hcv
virion
exit
cell
via
exosom
lowdens
particl
major
virion
contain
exit
cell
exosomeindepend
pathway
studi
found
presenc
microtubuledisrupt
drug
core
protein
fail
transport
ld
fig
result
accumul
core
protein
er
fig
addit
core
protein
coloc
microtubul
throughout
entir
figur
complex
transport
perinuclear
region
plasma
membran
via
microtubul
hcvinfect
cell
day
pi
label
antibodi
core
protein
red
b
blue
green
b
upper
row
blue
green
b
lower
row
tubulin
green
plasma
membran
nuclei
stain
wga
alexa
fluor
conjug
blue
b
dapi
gray
respect
second
third
panel
row
magnifi
view
mark
white
box
panel
extrem
left
perinuclear
peripher
region
cytoplasm
respect
coloc
core
depict
magenta
yellow
b
coloc
protein
complex
microtubul
plasma
membran
b
depict
white
microtubul
end
white
arrow
closest
cell
peripheri
b
right
enlarg
area
mark
white
box
merg
imag
coloc
core
protein
observ
membran
curvatur
white
arrow
pm
plasma
membran
bar
mm
c
quantit
antibodylabel
signal
viral
protein
plasma
membran
imag
cell
count
manual
use
origin
magnif
follow
quantit
analysi
perform
observ
blind
experiment
treatment
e
core
local
cluster
patch
plasma
membran
parallel
hcvinfect
cell
label
anticor
e
antibodi
bound
antibodi
detect
use
antimous
secondari
antibodi
conjug
gold
particl
section
visual
em
arrow
goldlabel
core
protein
e
f
immunoem
complex
coloc
plasma
membran
hcvinfect
cell
colabel
antibodi
nm
core
nm
shown
view
plasma
membran
arrowhead
goldlabel
arrow
goldlabel
core
pm
plasma
membran
bar
nm
f
nm
e
cytoplasm
mostli
also
associ
ld
fig
microtubul
end
near
plasma
membran
fig
result
suggest
intact
microtubul
network
serv
transport
highway
movement
hcv
viral
rc
core
protein
er
toward
ld
plasma
membran
viru
assembl
exit
addit
shown
interact
core
protein
ld
play
import
role
viru
assembl
core
protein
induc
redistribut
ld
perinuclear
region
viru
assembl
microtubuledepend
manner
figur
associ
exosom
protein
lowdens
hcv
particl
hcv
virion
popul
analyz
sucros
densiti
gradient
ultracentrifug
concentr
cultur
medium
collect
hcv
cell
fraction
use
continu
sucros
densiti
gradient
hcv
rna
level
determin
fraction
b
infect
densiti
gradient
fraction
aliquot
fraction
use
infect
naiv
cell
intracellular
hcv
rna
copi
number
per
mg
total
rna
determin
day
infect
qrtpcr
c
western
blot
analysi
densiti
gradient
fraction
shown
panel
use
antibodi
indic
left
e
f
electron
micrograph
viral
spheric
structur
shown
immunogold
label
hcv
particl
purifi
two
pool
fraction
lowdens
particl
fraction
highdens
particl
fraction
dialysi
concentr
viru
sampl
untreat
treat
saponin
e
f
describ
materi
method
grid
incub
untreat
saponintr
purifi
hcv
antibodi
antibodi
core
protein
e
respect
bound
antibodi
detect
use
antimous
rabbit
secondari
antibodi
conjug
gold
particl
f
complex
local
virion
core
lowdens
particl
grid
incub
saponintr
purifi
hcv
colabel
antibodi
nm
core
nm
determin
antibodi
specif
primari
antibodi
replac
nonspecif
normal
mous
igg
bar
nm
g
averag
diamet
low
n
highdens
n
particl
obtain
combin
analysi
two
independ
viral
prepar
error
bar
repres
standard
deviat
mean
h
statist
perform
count
hcv
particl
immunogold
label
hcv
particl
combin
analysi
two
independ
viral
prepar
rel
proport
hcv
particl
label
antibodi
n
studi
explain
previou
find
extracellular
viru
product
decreas
nocodazol
immunofluoresc
stain
em
found
close
associ
core
protein
almost
everi
step
hcv
life
cycl
wherea
involv
late
step
howev
small
number
signalscel
complex
detect
plasma
membran
cell
contrast
core
protein
alon
signalscel
fig
find
may
explain
amount
hcv
rna
ldf
copi
ml
significantli
lower
hdf
copiesml
fig
suggest
lowdens
hcv
particl
constitut
minor
popul
releas
hcv
virion
nonetheless
popul
appar
infecti
though
slightli
lower
specif
infect
bulk
viru
particl
hdf
fig
result
similar
publish
report
show
less
infect
lowdens
pool
densiti
howev
exclud
possibl
ldf
weak
infect
may
come
viru
contamin
hdf
notabl
demonstr
lowdens
hcv
particl
util
host
exosom
biogenesi
pathway
product
virion
lowdens
hcv
particl
densiti
gml
also
found
hepat
c
patient
serum
importantli
exosom
marker
coincid
core
protein
lowdens
fraction
fig
also
contain
hcv
rna
fig
complex
fig
exosom
marker
fig
detect
purifi
ldf
virion
correspondingli
exosom
marker
core
protein
coloc
plasma
membran
viru
releas
occur
reveal
immunofluoresc
stain
immunoem
fig
taken
togeth
result
indic
lowdens
virion
releas
cell
via
exosom
wherea
highdens
particl
exit
cell
via
altern
mechan
involv
exosom
pathway
consist
hypothesi
hcv
particl
found
associ
circul
exosom
serum
hcvinfect
patient
combin
previou
result
show
hcv
particl
transport
earli
late
endosomesmvb
current
studi
suggest
hcv
particl
like
exit
cell
via
fusion
mvb
plasma
membran
exosom
demonstr
facilit
bud
human
immunodefici
viru
hiv
hepat
viru
hav
exosom
known
play
import
role
intercellular
commun
hiv
hav
infect
exosom
requir
transinfect
cell
like
promot
viru
spread
within
liver
respect
similarli
exosomecontain
hcv
virion
might
fuse
uninfect
cell
mechan
independ
viral
envelop
protein
may
contribut
hcv
natur
infect
interact
core
protein
play
import
role
hcv
particl
product
mechan
involv
infecti
viru
product
still
unclear
associ
viral
ns
protein
viral
genom
rna
incorpor
viral
particl
common
among
rna
virus
influenza
viru
v
protein
simian
viru
coronaviru
vpx
viral
protein
x
howev
contrast
observ
merz
et
al
could
observ
viru
prepar
affin
purif
reason
discrep
may
lie
sensit
detect
method
method
viru
purif
detect
minor
popul
lowdens
particl
studi
also
possibl
affin
tag
use
previou
studi
could
detect
lowdens
hcv
particl
virionassoci
nonstructur
protein
probabl
play
structur
role
viru
particl
may
particip
yet
unknown
function
requir
differ
step
viral
life
cycl
recent
amphipath
ahel
peptid
ah
contain
ntermin
amino
acid
shown
induc
swell
vesicl
lead
vesicl
lysi
addit
infect
hcv
particl
reduc
hcv
virion
first
treat
ah
peptid
caus
disrupt
hcv
envelop
taken
togeth
data
present
elsewher
show
may
induc
fusion
lysi
lipid
vesicl
well
viru
particl
viru
entri
step
sinc
present
insid
viru
particl
like
membranealt
function
could
function
postbind
step
name
viru
envelop
disrupt
inde
postbind
fusion
step
within
acid
endosom
compart
requir
hcv
entri
interest
topic
studi
futur
summari
data
demonstr
minor
popul
lowdens
hcv
virion
releas
form
exosom
infect
cell
virion
core
contain
via
close
interact
core
protein
intracellular
transport
studi
provid
addit
target
design
new
therapeut
approach
possibl
use
exosom
inhibitor
block
spread
hcv
infect
figur
hcvinfect
cell
day
pi
fix
process
em
right
enlarg
area
largediamet
white
arrow
smalldiamet
b
black
arrow
hcvlike
particl
releas
plasma
membran
pm
plasma
membran
bar
nm
left
panel
nm
right
panel
tif
